首页 > 市场调查报告书 > 医疗设备

电子医疗设备

神经刺激设备市场规模、份额和成长分析（按产品、应用和地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1902337

神经刺激设备市场规模、份额和成长分析（按产品、应用和地区划分）－2026-2033年产业预测

Neurostimulation Devices Market Size, Share, and Growth Analysis, By Product (Spinal Cord Stimulator, Deep Brain Stimulator), By Application (Pain Management, Epilepsy), By Region - Industry Forecast 2026-2033

出版日期: 2025年12月23日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，神经刺激设备市场规模将达到 67.5 亿美元，到 2025 年将成长至 76.1 亿美元，到 2033 年将成长至 199.6 亿美元，在预测期（2026-2033 年）内复合年增长率为 12.8%。

神经刺激设备市场预计将因神经系统疾病盛行率的上升和神经系统研究投入的增加而显着增长。人们对这些疾病的认识不断提高，以及对有效治疗方法的需求不断增长，为该领域的从业者带来了巨大的机会。基于广泛研究的技术进步有望促进销售成长，而微创手术方式的普及也可能进一步刺激需求。此外，神经刺激手术报销政策的改善以及人们对其益处的认识不断提高，也将为市场参与者创造新的商机。然而，潜在的併发症、先进设备的高成本以及熟练专业人员的短缺等挑战可能会阻碍市场的成长前景。

神经刺激设备市场驱动因素

神经退化性疾病的增加归因于不健康的生活方式，导致患有各种神经系统疾病的患者数量显着增加。帕金森氏症、癫痫、慢性疼痛和忧郁症疾病的盛行率日益上升，推动了对神经刺激设备的需求。这些设备提供的治疗方案能够改善患者的生活质量，对于管理和治疗这些健康问题至关重要。随着越来越多的人寻求针对这些疾病的有效干预措施，神经刺激技术的重要性与日俱增，凸显了其在旨在应对复杂神经系统挑战的现代医疗策略中的核心地位。

限制神经刺激设备市场的因素

由于操作这些先进技术所需的熟练医疗专业人员严重短缺，神经刺激设备市场面临严峻挑战。随着这些先进医疗设备复杂性的增加，对高素质人员的需求也日益增长。然而，这种专业人才的匮乏可能会阻碍神经刺激设备市场的成长和扩张，因为合格操作人员的缺乏限制了设备的普及和使用。这反过来又会抑制产业的进步和创新潜力，阻碍患者获得最佳治疗效果，并最终使依赖这些重要治疗方案的患者受益。

神经刺激设备市场趋势

在精准医疗需求日益增长的推动下，神经刺激设备市场正经历着向个人化解决方案的重大转变。这一趋势反映出人们越来越认识到患者神经系统特征的独特性，从而催生出能够改善慢性疼痛和癫痫等疾病治疗效果的客製化疗法。科技的进步使得神经刺激设备能无缝适应特定患者的需求，进而提升患者的治疗效果。随着医疗服务提供者和患者都接受这种个人化方法，预计市场将蓬勃发展，提供不仅能够缓解症状，还能有效解决潜在神经系统问题的创新解决方案。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Medtronic（Ireland）
Abbott Laboratories（USA）
Boston Scientific Corporation（USA）
Nevro Corporation（USA）
LivaNova PLC（UK）
NeuroPace, Inc.（USA）
Neuronetics, Inc.（USA）
Axonics Modulation Technologies, Inc.（USA）
Cochlear Limited（Australia）
ElectroCore, Inc.（USA）
Aleva Neurotherapeutics SA（Switzerland）
Soterix Medical（USA）
Bioinduction（United Kingdom）
Oticon Medical（Denmark）

结论与建议

简介目录

Product Code: SQMIG35B2087

Neurostimulation Devices Market size was valued at USD 6.75 Billion in 2024 and is poised to grow from USD 7.61 Billion in 2025 to USD 19.96 Billion by 2033, growing at a CAGR of 12.8% during the forecast period (2026-2033).

The neurostimulation devices market is poised for significant growth, driven by increasing prevalence of neurological disorders and escalating investments in neurological research. Rising awareness of these conditions and the corresponding demand for effective treatments present lucrative opportunities for providers in this sector. Technological advancements rooted in extensive research are set to enhance sales, while the shift toward minimally invasive surgical options is likely to further boost demand. Additionally, improved reimbursement options for neurostimulation procedures and heightened awareness of their benefits will create new business avenues for market players. However, challenges such as potential complications, high costs of advanced devices, and a shortage of skilled professionals may hinder market growth prospects.

Top-down and bottom-up approaches were used to estimate and validate the size of the Neurostimulation Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Neurostimulation Devices Market Segments Analysis

Global Neurostimulation Devices Market is segmented by Product, Application and region. Based on Product, the market is segmented intoSpinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator and Gastric Electric Stimulator. Based on Application, the market is segmented into Pain Management, Epilepsy, Essential Tremor, Urinary & Fecal Incontinence, Depression, Dystonia, Gastroparesis, Parkinson's Disease and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Neurostimulation Devices Market

The rise in neurodegenerative diseases can be attributed to unhealthy lifestyle choices, leading to a notable increase in individuals affected by various neurological disorders. Conditions such as Parkinson's disease, epilepsy, chronic pain, and depression have become increasingly prevalent, driving the demand for neurostimulation devices. These devices are essential in managing and treating these health issues, offering therapeutic solutions that enhance patients' quality of life. As more people seek effective interventions for these disorders, the relevance of neurostimulation technology continues to grow, highlighting its importance in contemporary healthcare strategies aimed at addressing complex neurological challenges.

Restraints in the Neurostimulation Devices Market

The neurostimulation devices market faces significant challenges due to a critical shortage of skilled medical professionals required for the effective operation of these sophisticated technologies. As the complexity of these advanced medical devices increases, the demand for highly trained personnel also rises. Unfortunately, this lack of expertise may hinder the growth and expansion of the neurostimulation devices market, as the absence of qualified operators can limit accessibility and utilization. Consequently, the industry's potential for advancement and innovation may be stifled, creating barriers to achieving optimal outcomes and benefiting patients who might rely on these critical therapeutic solutions.

Market Trends of the Neurostimulation Devices Market

The neurostimulation devices market is witnessing a significant shift towards personalized solutions, driven by the growing preference for individualized medicine. This trend reflects an increasing recognition of the unique neurological profiles of patients, leading to tailored therapies that enhance treatment efficacy for conditions such as chronic pain and epilepsy. The advancement in technology allows neurostimulation devices to adapt seamlessly to specific patient needs, fostering improved patient outcomes. As healthcare providers and patients alike embrace these personalized approaches, the market is expected to flourish, providing innovative solutions that not only address symptoms but also target the underlying neurological patterns effectively.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Analysis

Global Neurostimulation Devices Market Size by Product & CAGR (2026-2033)

Market Overview
Spinal Cord Stimulator
Deep Brain Stimulator
Sacral Nerve Stimulator
Vagus Nerve Stimulator
Gastric Electric Stimulator

Global Neurostimulation Devices Market Size by Application & CAGR (2026-2033)

Market Overview
Pain Management
Epilepsy
Essential Tremor
Urinary & Fecal Incontinence
Depression
Dystonia
Gastroparesis
Parkinson's Disease
Others

Global Neurostimulation Devices Market Size & CAGR (2026-2033)

North America (Product, Application)
- US
- Canada
Europe (Product, Application)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Application)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Application)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Application)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Medtronic (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nevro Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LivaNova PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NeuroPace, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neuronetics, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Axonics Modulation Technologies, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cochlear Limited (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ElectroCore, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aleva Neurotherapeutics SA (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Soterix Medical (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioinduction (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oticon Medical (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments